Article info

Download PDFPDF

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

Authors

  • Alessia Alunno Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy PubMed articlesGoogle scholar articles
  • Aurélie Najm Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK PubMed articlesGoogle scholar articles
  • Pedro M Machado Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UKNational Institute for Health Research (NIHR) Biomedical Research Centre (BRC), University College London Hospitals NHS Foundation Trust, London, UKDepartment of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Heidi Bertheussen Oslo, Norway PubMed articlesGoogle scholar articles
  • Gerd R Burmester Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Freie Universität und Humboldt-Universität Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Francesco Carubbi Department of Medicine, ASL 1 Avezzano-Sulmona-L'Aquila, Internal Medicine and Nephrology Unit, Department of Life, Health & Environmental Sciences, University of L’Aquila, L'Aquila, Italy PubMed articlesGoogle scholar articles
  • Gabriele De Marco The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Roberto Giacomelli Rheumatology and Clinical Immunology Unit, University of Rome "Campus Biomedico" School of Medicine Rome, Rome, Italy PubMed articlesGoogle scholar articles
  • Olivier Hermine Department of Haematology, Hôpital Necker, Assistance Publique - Hôpitaux de Paris, Paris, FranceINSERM UMR1183, Institut Imagine, Université de Paris, Paris, France PubMed articlesGoogle scholar articles
  • John D Isaacs Translational and Clinical Research Institute, Newcastle University and Musculoskeletal Unit, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Isabelle Koné-Paut Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies Auto-Inflammatoires de l’enfant, Hôpital Bicêtre, AP HP, Université Paris Sud, Bicètre, France PubMed articlesGoogle scholar articles
  • César Magro-Checa Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands PubMed articlesGoogle scholar articles
  • Iain McInnes Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK PubMed articlesGoogle scholar articles
  • Pier Luigi Meroni Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Milan, Italy PubMed articlesGoogle scholar articles
  • Luca Quartuccio Department of Medicine, Rheumatology Clinic, University of Udine, ASUFC Udine, Udine, Italy PubMed articlesGoogle scholar articles
  • Athimalaipet V Ramanan University Hospitals Bristol NHS Foundation Trust, Bristol, UKUniversity of Bristol Translational Health Sciences, Bristol, UK PubMed articlesGoogle scholar articles
  • Manuel Ramos-Casals Department of Autoimmune Diseases, ICMiD, Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, University of Barcelona, Hospital Clínic, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Javier Rodríguez Carrio Department of Functional Biology, Immunology Area, Faculty of Medicine, University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain PubMed articlesGoogle scholar articles
  • Hendrik Schulze-Koops Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians University of Munich, Munchen, Germany PubMed articlesGoogle scholar articles
  • Tanja A Stamm Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna and Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Wien, Austria PubMed articlesGoogle scholar articles
  • Sander W Tas Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centres, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Benjamin Terrier Department of Internal Medicine, Cochin University Hospital, Paris, France; National Referral Centre for Systemic and Autoimmune Diseases, University Paris Descartes, Sorbonne Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Dennis G McGonagle The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Xavier Mariette Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, INSERM UMR1184, Department of Rheumatology, Université Paris-Saclay, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Xavier Mariette, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, INSERM UMR1184, Department of Rheumatology, Université Paris-Saclay, 91190 Saint-Aubin, Île-de-France, France; xavier.mariette{at}aphp.fr
View Full Text

Citation

Alunno A, Najm A, Machado PM, et al
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

Publication history

  • Received December 15, 2020
  • Revised January 11, 2021
  • Accepted January 27, 2021
  • First published February 5, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.